Author:
van Gils M.P.M.Q.,Stenman U.H.,Schalken J.A.,Schröder F.H.,Luider T.M.,Lilja H.,Bjartell A.,Hamdy F.C.,Pettersson K.S.I.,Bischoff R.,Takalo H.,Nilsson O.,Mulders P.F.A.,Bangma C.H.
Reference59 articles.
1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5. version 2 0, IARC Press, Lyon 2004.
2. Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma;Kikuchi;Cancer,2000
3. Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer;Cannon;Urology,2003
4. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening;Catalona;JAMA,1995
5. Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening;Finne;Int J Cancer,2004
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献